MYC and leukemia: Ma et al. reported that one of berberine derivations, quinolino-benzo-[5,6]-dihydroisoquindolium compound, inhibited the c-Myc transcription by selectively binding G-quadruplex c-Myc DNA in leukemia cell line HL60 [28].